Diabetes, Constipation, Sleep disorders, Overactive bladder
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients 1. Those who are at least 18 years of age and visited the participating institutions during the study period. 2. Those who were eligible to submit a tracing report. 3. Those who understood the opt-out document and did not refuse to cooperate. Pharmacists 1. Those who received an explanation of the implementation procedures from the principal investigator at the research site and who attended to patients who were eligible to submit a tracing report. 2. Those who gave consent
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the number of tracing reports submitted by pharmacists to attending physicians on the subject drug | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Changes in the number of tracing reports submitted for all drugs, including those not covered in this study 2. Changes in the content of text information in tracing reports 3. Change in the number of additional service fee of the NHI system 4. Change in the percentage of the number of tracing reports generated out of the number of follow-ups during the medication period | — |
Countries
Japan
Contacts
Niigata University of Pharmacy and Applied Life Sciences School of Pharmacy, Laboratory of Social Pharmacy